Minsu Kang

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical genetics (excl. cancer genetics)Predictive and prognostic markersBiogeography and phylogeography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 23, 2026
SRC Activation Drives Acquired Pemetrexed Resistance in Non-Small Cell Lung Cancer and Is Targetable by Dasatinib.

|Nov 13, 2025
Pertuzumab Enhances the Antitumor Activity of T-DXd in HER2-Positive Gastric Cancer Cells.

Minsu Kang, Kui-Jin Kim, Hyeon Jeong Oh

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

|Sep 26, 2025
VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation.

Sung-Hyun Hwang, Mingyun Bae, Ji-Won Kim

|Jun 11, 2024
Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study.

Ji Yun Lee, Ju-Hyun Lee, Jeongmin Seo

|Nov 21, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.

Yoojoo Lim, Songji Choi, Hyeon Jeong Oh

Pageof 2

Frequent Collaborators

7 joint publications

Ji-Won Kim

5 joint publications

Se Hyun Kim

5 joint publications

Keun-Wook Lee

4 joint publications

Jin Won Kim